AIM
MXCT icon

AXA Investment Managers’s MaxCyte MXCT Stock Holding History

AXA Investment Managers’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.38M Buy
+2,773,554
New +$4.82M 0.01% 600

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

AXA Investment Managers's MXCT Position: Q3 2025 in Review

AXA Investment Managers opened a new position in MaxCyte (MXCT) in Q3 2025: 2,773,554 shares worth $4.38M. The stake represents 0.01% of the portfolio and ranks #600 among its holdings.

112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • AXA Investment Managers held 2,773,554 shares of MaxCyte worth $4.38M as of Q3 2025.
  • MaxCyte was a new AXA Investment Managers position in Q3 2025.
  • MaxCyte made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #600 holding.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.